California Heart Center Foundation is located in Beverly Hills, CA. The organization was established in 2004. According to its NTEE Classification (H90) the organization is classified as: Medical Disciplines Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. California Heart Center Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2020, California Heart Center Foundation generated $2.5m in total revenue. This represents relatively stable growth, over the past 6 years the organization has increased revenue by an average of 4.2% each year. All expenses for the organization totaled $2.4m during the year ending 12/2020. While expenses have increased by 2.0% per year over the past 6 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2020
Describe the Organization's Mission:
Part 3 - Line 1
PROMOTE & DEVELOP EDUCATIONAL & SCIENTIFIC RESEARCH TO ADVANCE THE FIELD OF CARDIOVASCULAR MEDICINE.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE MISSION OF THE CALIFORNIA HEART CENTER FOUNDATION IS TO ADVANCE THE FIELD OF CARDIOVASCULAR MEDICINE THROUGH CLINICAL RESEARCH INITIATIVES AND EDUCATIONAL INITIATIVES. OUR EFFORTS INCLUDE THE PURSUIT OF COLLABORATIVE RESEARCH PROJECTS WHICH PROMOTE A DEEPER UNDERSTANDING OF DISEASE PROGRESSION AND TEST THE EFFICACY OF NEW STRATEGIES FOR DIAGNOSIS AND TREATMENT. AREAS OF RESEARCH CURRENTLY BEING PURSUED INCLUDE NON-INVASIVE METHODS TO DETECT ORGAN REJECTION, NOVEL IMMUNOSUPPRESSIVE AGENTS, IMMUNE MONITORING STRATEGIES, LONG-TERM COMPLICATIONS SUCH AS CARDIAC ALLOGRAFT VASCULOPATHY, (CONTINUED ON SCHEDULE O)(CONTINUATION FROM FORM 990, PAGE 2)NOVEL METHODS FOR ORGAN PROCUREMENT AND PRESERVATION, NEW MECHANICAL CIRCULATORY SUPPORT DEVICES AND PULMONARY HYPERTENSION. THE ORGANIZATION ALSO SUPPORTS IMPORTANT SCIENTIFIC SYMPOSIA, WHICH ALLOW FOR THE EXCHANGE OF IDEAS AMONG LEADERS IN THE FIELD AND PROVIDE A FORUM FOR EXPERTS TO SHARE THEIR EXPERIENCE AND KNOWLEDGE WITH OTHER PRACTITIONERS. THE ORGANIZATION RESOURCES ARE ALSO LEVERAGED TO SUPPORT A SUMMER RESEARCH INTERNSHIP PROGRAM FOR UNDERGRADUATE STUDENTS WITH AN INTEREST IN MEDICINE AND/OR ACADEMIC RESEARCH. FOLLOWING IS A SUMMARY OF PROJECTS AND PROGRAMS IMPLEMENTED IN 2021: SCIENTIFIC FORUMS AND EDUCATIONAL ACTIVITIES:* "CUTTING EDGE OF TRANSPLANTATION (CEOT)" FEBRUARY 25-27, 2021 (VIRTUAL)THIS ANNUAL CONFERENCE WAS HELD BY THE AMERICAN SOCIETY OF TRANSPLANTATION, WITH CONTENT DEVELOPED WITH A THEMATIC FOCUS ON "INNOVATIONS IN MODERN IMMUNOSUPPRESSION." SESSIONS FOCUSED ON HEART AND LUNG TRANSPLANTATION WERE DESIGNED, ORGANIZED AND CHAIRED BY DR. KOBASHIGAWA. DUE TO COVID-19, THE MEETING WAS CONVERTED TO A VIRTUAL PLATFORM. HOWEVER, ATTENDANCE REMAINED STRONG WITH MORE THAN 1/3 OF PARTICIPANTS FROM THE THORACIC COMMUNITY. FEEDBACK FOR THE HEART AND LUNG SESSIONS WAS HIGHLY POSITIVE. * SUMMER RESEARCH INTERNSHIPS: UNDER THE SUPERVISION AND MENTORSHIP OF DR. JON KOBASHIGAWA, SUMMER HEART TRANSPLANT RESEARCH INTERNSHIPS HAVE BEEN OFFERED TO STUDENTS FOR THE SUMMER OF 2021. THESE INTERNSHIPS PROVIDE STUDENTS AT ALL LEVELS OF TRAINING AN OPPORTUNITY TO LEARN THE CLINICAL RESEARCH PROCESS, INCLUDING MEDICAL LITERATURE REVIEW, STUDY DESIGN, CHART REVIEW/DATA COLLECTION, DATA ANALYSIS, AND ABSTRACT DEVELOPMENT AND SUBMISSION. COMPLETED ABSTRACTS WERE SUBMITTED TO THE AMERICAN FEDERATION OF MEDICAL RESEARCH, A FORUM FOR JUNIOR INVESTIGATORS. THIS YEAR'S GROUP INCLUDES STUDENTS FROM:FLORIDA A&M UNIVERSITYUNIVERSITY OF CALIFORNIA, LOS ANGELESUNIVERSITY OF CALIFORNIA, SANTA BARBARASANTA CLARA UNIVERSITYVASSAR COLLEGE WESTERN UNIVERSITY MEDICAL SCHOOL* HEART TRANSPLANT JOURNAL CLUBSJOURNAL CLUBS CONTINUE TO BE HELD IN A VIRTUAL FORMAT AND HAVE MAINTAINED STRONG PARTICIPATION, WITH AN AVERAGE ATTENDANCE OF 25 PEOPLE AT EACH SESSION. THE FOLLOWING SESSION(S) HAVE BEEN IMPLEMENTED OR SCHEDULED: MONDAY, SEPTEMBER 27TH, 2021 - 5:00PM - 6:00PM "HEART-AFTER-LIVER TRANSPLANTATION ATTENUATES REJECTION OF CARDIAC ALLOGRAFTS IN SENSITIZED PATIENTS" PRESENTER: DR. ANDREW CHENG WEDNESDAY, DECEMBER 1ST, 2021 - 5:00PM - 6:00PM "THIRD DOSE OF THE BNT162B2 VACCINE IN HEART TRANSPLANT RECIPIENTS: IMMUNOGENICITY AND CLINICAL EXPERIENCE" PRESENTER: DR. AZRA BHIMANI* "THOMAS D. GORDON VISITING PROFESSOR IN ADVANCED HEART DISEASE" (VIRTUAL)THIS ANNUAL VISITING PROFESSORSHIP HAS CONTINUED TO BE SPONSORED AND ORGANIZED BY DR. KOBASHIGAWA. THIS YEAR WE HAD THE HONOR OF HOSTING DR. BARTLEY GRIFFITH, FROM THE UNIVERSITY OF MARYLAND. THIS VIRTUAL VISIT, HELD ON SEPTEMBER 28TH, 2021, INCLUDED A GRAND ROUNDS LECTURE, ONE TO ONE FACULTY MEETINGS AND A FELLOWS' PROFESSIONAL DEVELOPMENT DISCUSSION. DR. GRIFFITH'S LECTURE ON "CURRENT PROGRESS FOR XENOTRANSPLANT OF THE HEART: WILL IT BE A CLINICAL REALITY SOON?" WAS ESPECIALLY TIMELY, AS DR. GRIFFITH COMPLETED THE FIRST HUMAN XENOTRANSPLANT SURGERY IN JANUARY OF 2022, BREAKING EXCITING NEW GROUND IN THE FIELD.* "HEART FAILURE POTPOURRI" BY DR. MICHELLE KITTLESON, OCTOBER 15TH, 2021THIS VIRTUAL EDUCATIONAL PRESENTATION BY DR. KITTLESON WAS HELD AT THE REQUEST OF RESEARCH STAFF, TO GAIN A BETTER UNDERSTANDING OF COMMON PROCEDURES, TREATMENTS, SECONDARY DIAGNOSES, AND OTHER COMPLEXITIES OF HEART FAILURE AS THEY APPROACH RESEARCH PROTOCOLS. THE INTIMATE SETTING PROVIDED THE TEAM WITH AN OPPORTUNITY FOR A ROBUST Q&A SESSION AND DISCUSSION WITH DR. KITTLESON. CLINICAL RESEARCH:THIS SECTION IS FORMATTED BY CATEGORY; STUDY NAME; PRINCIPAL INVESTIGATOR (PI).
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Michele Hamilton Treasurer | OfficerTrustee | 2 | $0 |
Jon Kobashigawa MD President | OfficerTrustee | 2 | $0 |
Christine Sumbi Secretary | Officer | 40 | $0 |
Eduardo Marban MD Director | Trustee | 1 | $0 |
Thomas D Gordon Director | Trustee | 1 | $0 |
Jaime Moriguchi MD Director | Trustee | 2 | $0 |
Statement of Revenue | |
---|---|
Total Revenue from Contributions, Gifts, Grants & Similar | $2,136,097 |
Investment income | $0 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $2,474,527 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $223,470 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $1,098,789 |
Pension plan accruals and contributions | $71,456 |
Other employee benefits | $148,922 |
Payroll taxes | $110,960 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $0 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $53,054 |
Advertising and promotion | $0 |
Office expenses | $2,715 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $529,576 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $123,088 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $0 |
All other expenses | $0 |
Total functional expenses | $2,376,586 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $198,098 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $396 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $198,494 |
Accounts payable and accrued expenses | $255,504 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $255,504 |
Net assets without donor restrictions | $0 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Total liabilities and net assets/fund balances | -$57,010 |
Over the last fiscal year, we have identified 2 grants that California Heart Center Foundation has recieved totaling $20,000.
Awarding Organization | Amount |
---|---|
Hyman Levine Family Foundation Ldor Vdor Beverly Hills, CA PURPOSE: CHARITY/EDUCATION | $10,000 |
Hyman Levine Family Foundation Ldor Vdor Beverly Hills, CA PURPOSE: CHARITY/EDUCATION | $10,000 |
Organization Name | Assets | Revenue |
---|---|---|
Veterans Medical Research Foundation Of Sd San Diego, CA | $7,321,086 | $16,367,755 |
Huntington Medical Research Institutes Pasadena, CA | $82,259,720 | $16,674,865 |
International Anesthesia Research Society San Francisco, CA | $39,176,119 | $7,595,072 |
California Heart Center Foundation Beverly Hills, CA | $198,494 | $2,474,527 |
House Institute Foundation Los Angeles, CA | $6,887,696 | $1,568,325 |
Fanconi Anemia Research Fund Inc Eugene, OR | $8,601,390 | $4,056,234 |
The Gpcr Institute San Marcos, CA | $1,290,580 | $0 |
Musculoskeletal-Orthopedic Research And Education Foundation Phoenix, AZ | $591,829 | $1,272,150 |
Terasaki Innovation Center Inc Glendale, CA | $6,320,184 | $1,253,217 |
Chan Soon-Shiong Nanthealth Foundation El Segundo, CA | $24,916,368 | $63,681 |
Stemexpress Foundation Folsom, CA | $222,954 | $249,620 |
Alles Institute For Medical Research El Cerrito, CA | $8,526,362 | $1,074,198 |